CF
RXST icon

Corebridge Financial’s RxSight RXST Stock Holding History

Corebridge Financial’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18,070
Closed -$456K – 2256
2025
Q1 		$456K Buy
18,070
+14
+0.1% +$416 ﹤0.01% 1644
2024
Q4 		$621K Sell
18,056
-1,134
-6% -$51.1K ﹤0.01% 1562
2024
Q3 		$949K Buy
19,190
+887
+5% +$45.4K 0.01% 1381
2024
Q2 		$1.1M Buy
+18,303
New +$1.05M 0.01% 1278

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Corebridge Financial's RXST Position: Q2 2025 in Review

Corebridge Financial sold out of RxSight (RXST) in Q2 2025, closing a stake of 18,070 shares — an estimated $456K sold.

Corebridge Financial first reported a position in RXST in Q2 2024 and held it in 4 quarters. The position peaked at $1.1M in Q2 2024. 174 funds tracked by Wall St. Rank hold RXST as of Q2 2025.

  • Corebridge Financial reported no remaining RxSight position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 18,070 RxSight shares in Q2 2025, an estimated $456K.
  • Corebridge Financial first reported a position in RxSight in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's RxSight position peaked at $1.1M in Q2 2024.
  • 174 funds tracked by Wall St. Rank held RxSight as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.